BACKGROUND: Stratification of individuals at risk for chronic kidney disease may allow optimization of preventive measures to reduce disease incidence and complications. We sought to develop a risk score that estimates an individual's absolute risk of incident chronic kidney disease. METHODS: Framingham Heart Study participants free of baseline chronic kidney disease, who attended a baseline examination in 1995-1998 and follow-up in 2005-2008, were included in the analysis (n = 2490). Chronic kidney disease was defined as an estimated glomerular filtration rate <60 mL/min/1.73 m(2) using the Modification of Diet in Renal Disease equation. Participants were assessed for the development of chronic kidney disease at 10 years follow-up. Stepwise logistic regression was used to identify chronic kidney disease risk factors, and these were used to construct a risk score predicting 10-year chronic kidney disease risk. Performance characteristics were assessed using calibration and discrimination measures. The final model was externally validated in the bi-ethnic Atherosclerosis Risk in Communities Study (n = 1777). RESULTS: There were 1171 men and 1319 women at baseline, and the mean age was 57.1 years. At follow-up, 9.2% (n = 229) had developed chronic kidney disease. Age, diabetes, hypertension, baseline estimated glomerular filtration rate, and albuminuria were independently associated with incident chronic kidney disease (P <.05), and these covariates were incorporated into a risk function (c-statistic 0.813). In external validation in the ARIC study, the c-statistic was 0.74 in whites (n = 1353) and 0.75 in blacks (n = 424). CONCLUSION: Risk stratification for chronic kidney disease is achievable using a risk score derived from clinical factors that are readily accessible in primary care. The utility of this score in identifying individuals in the community at high risk of chronic kidney disease warrants further investigation. Published by Elsevier Inc.
BACKGROUND: Stratification of individuals at risk for chronic kidney disease may allow optimization of preventive measures to reduce disease incidence and complications. We sought to develop a risk score that estimates an individual's absolute risk of incident chronic kidney disease. METHODS: Framingham Heart Study participants free of baseline chronic kidney disease, who attended a baseline examination in 1995-1998 and follow-up in 2005-2008, were included in the analysis (n = 2490). Chronic kidney disease was defined as an estimated glomerular filtration rate <60 mL/min/1.73 m(2) using the Modification of Diet in Renal Disease equation. Participants were assessed for the development of chronic kidney disease at 10 years follow-up. Stepwise logistic regression was used to identify chronic kidney disease risk factors, and these were used to construct a risk score predicting 10-year chronic kidney disease risk. Performance characteristics were assessed using calibration and discrimination measures. The final model was externally validated in the bi-ethnic Atherosclerosis Risk in Communities Study (n = 1777). RESULTS: There were 1171 men and 1319 women at baseline, and the mean age was 57.1 years. At follow-up, 9.2% (n = 229) had developed chronic kidney disease. Age, diabetes, hypertension, baseline estimated glomerular filtration rate, and albuminuria were independently associated with incident chronic kidney disease (P <.05), and these covariates were incorporated into a risk function (c-statistic 0.813). In external validation in the ARIC study, the c-statistic was 0.74 in whites (n = 1353) and 0.75 in blacks (n = 424). CONCLUSION: Risk stratification for chronic kidney disease is achievable using a risk score derived from clinical factors that are readily accessible in primary care. The utility of this score in identifying individuals in the community at high risk of chronic kidney disease warrants further investigation. Published by Elsevier Inc.
Authors: Andrew S Levey; Sharon P Andreoli; Thomas DuBose; Robert Provenzano; Allan J Collins Journal: Am J Kidney Dis Date: 2007-02 Impact factor: 8.860
Authors: Andrew D Rule; Timothy S Larson; Erik J Bergstralh; Jeff M Slezak; Steven J Jacobsen; Fernando G Cosio Journal: Ann Intern Med Date: 2004-12-21 Impact factor: 25.391
Authors: Andrew S Levey; Kai-Uwe Eckardt; Yusuke Tsukamoto; Adeera Levin; Josef Coresh; Jerome Rossert; Dick De Zeeuw; Thomas H Hostetter; Norbert Lameire; Garabed Eknoyan Journal: Kidney Int Date: 2005-06 Impact factor: 10.612
Authors: Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey Journal: JAMA Date: 2007-11-07 Impact factor: 56.272
Authors: A S Levey; R Atkins; J Coresh; E P Cohen; A J Collins; K-U Eckardt; M E Nahas; B L Jaber; M Jadoul; A Levin; N R Powe; J Rossert; D C Wheeler; N Lameire; G Eknoyan Journal: Kidney Int Date: 2007-06-13 Impact factor: 10.612
Authors: Conall M O'Seaghdha; Shih-Jen Hwang; Martin G Larson; James B Meigs; Ramachandran S Vasan; Caroline S Fox Journal: J Am Soc Nephrol Date: 2013-08-29 Impact factor: 10.121
Authors: Daniela Dunkler; Peggy Gao; Shun Fu Lee; Georg Heinze; Catherine M Clase; Sheldon Tobe; Koon K Teo; Hertzel Gerstein; Johannes F E Mann; Rainer Oberbauer Journal: Clin J Am Soc Nephrol Date: 2015-07-14 Impact factor: 8.237
Authors: James I Hudson; Gen Kanayama; Harrison G Pope; Samantha Muse; Marc J Kaufman; Aaron Baggish; Sushrut S Waikar Journal: Am J Kidney Dis Date: 2020-04-30 Impact factor: 8.860
Authors: Pankti A Gheewala; Syed Tabish R Zaidi; Matthew D Jose; Luke Bereznicki; Gregory M Peterson; Ronald L Castelino Journal: J Nephrol Date: 2017-02-08 Impact factor: 3.902
Authors: Matthew R Beymer; Robert E Weiss; Catherine A Sugar; Linda B Bourque; Gilbert C Gee; Donald E Morisky; Suzanne B Shu; Marjan Javanbakht; Robert K Bolan Journal: Sex Transm Dis Date: 2017-01 Impact factor: 2.830
Authors: Conall M O'Seaghdha; Shih-Jen Hwang; Jennifer E Ho; Ramachandran S Vasan; Daniel Levy; Caroline S Fox Journal: J Am Soc Nephrol Date: 2013-06-13 Impact factor: 10.121